Concepedia
Statistics
Publications
20
Citations
843
H-Index
17
Active since
2004
Affiliations
KU Leuven(Current)
University Medical Center Groningen
VIB-KU Leuven Center for Cancer Biology
University of Groningen
The University of Texas MD Anderson Cancer Center
Kim R. Kampen is an author at KU Leuven specializing in medicine, cell biology, and cancer research.
Top concepts
MedicineCell BiologyCancer ResearchOncologyTumor BiologyRadiation OncologyPharmacologyGene ExpressionTobacco ControlImmunology
Publications per year
2004–2023
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types
Laura Fancello, Kim R. Kampen, Isabel Juliana Hofman et al. · Oncotarget · 2017 · 120 citations · Full text
Ribosomal Protein Genes, Oncology, Medicine +14
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
Kim R. Kampen, Laura Fancello, Tiziana Girardi et al. · Nature Communications · 2019 · 103 citations · Full text
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
Shauni Lien Geeraerts, Kim R. Kampen, Gianmarco Rinaldi et al. · Molecular Cancer Therapeutics · 2020 · 78 citations · Full text
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
Tiziana Girardi, Stijn Vereecke, Sergey O. Sulima et al. · Leukemia · 2017 · 77 citations · Full text
Hematological Malignancy, Mixed-phenotype Acute Leukemia, Immunology +6
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
Kim R. Kampen, Sergey O. Sulima, Benno Verbelen et al. · Leukemia · 2018 · 70 citations · Full text
Natural Sciences, Genetics, Ires-dependent Bcl-2 Translation +7
Rows per page
1–5 of 20